-
Building for the future of Regenerative Medicine in Edinburgh
Oct 23The CRM is marking the beginning of construction of the Centre of Tissue Repair. Together with the Centre of Regenerative Medicine, they will form the Institute for Regeneration and Repair.
-
Cell-based therapies could be boosted by new antioxidant
Sep 20Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their survival, new CRM research suggests.
-
Blindness study shows how gene causes middle-age sight loss
Sep 5Chemical changes in the eye that can lead to blindness have been identified by a team led by former CRM researcher Dr Roly Megaw.
-
New “backup” liver repair mechanism
Jul 12New study reveals cells can be reprogrammed to repair severe liver injury.
-
An art exhibition, by CRM scientists
Jun 9The MRC Centre for Regenerative Medicine will be a hosting a pop-up art exhibit on 22 June. Regeneration: A story of becoming, will feature original artworks created by scientists from the centre. The exhibition is a part of the Medical Research Council’s annual Festival of Medical Research.
-
Cigarette damage to unborn children revealed in stem cell study
May 30Chemicals found in cigarette smoke have been shown to damage foetal liver cells.
-
Stem cell-derived macrophages could treat liver fibrosis
May 24Macrophages derived from embryonic stem cells in the laboratory reduce tissue damage in a mouse model of chronic liver disease.
-
Brain tumours exploit proteins that control normal brain stem cells
May 12CRM researchers have pinpointed two key molecules that drive the growth of an aggressive type of adult brain cancer.
-
Charles ffrench-Constant elected Fellow of the Academy of Medical Sciences
May 10Former CRM Director and Principal Investigator, Professor Charles ffrench-Constant has been elected to the prestigious Fellowship of the Academy of Medical Sciences.
-
New Mechanism of Repair in the Testes Offers Hope for Fertility
May 4CRM scientists have discovered a tiny group of cells that is critical to repairing damage to the testes.
-
£0.9m Commercial collaboration to improve blood cell production from stem cells
Apr 27CRM scientists have joined forces with Plasticell to secure £920,000 Biomedical Catalyst funding from Innovate UK.
-
New Collaboration to Accelerate Drug Discovery Using Stem Cell Technology
Mar 6The MRC-Centre for Regenerative Medicine (MRC-CRM) and the University of Dundee have announced a new collaboration to encourage partnership with the pharmaceutical industry.
-
Blood study provides hope for stem cell therapy
Feb 15CRM researchers have pinpointed a key enzyme that is vital for the production of all blood cells in the body.
-
New opportunities for screening models in brain cancer
Feb 14CRM scientists have been able to make precise genetic changes to mouse and human neuronal stem cells for the first time. This opens up the possibility for the study of the genetic changes seen in glioblastoma, the most common form of brain cancer.
-
New clues to cause of bile duct cancer
Oct 11Scientists at the CRM have identified a molecule that drives the development of bile duct cancer. The research in mice and human cells sheds new light on what triggers the disease and how the illness progresses.
-
New insights into blood cancer that develops before birth
Jul 7Researchers from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh have identified the cells responsible for a form of leukaemia that can develop while a baby is in the womb.
-
Edinburgh scientists to get £3.7million CRUK funding for cutting edge cancer research
May 13Edinburgh scientists are set to receive a major cash boost from Cancer Research UK which could help to develop groundbreaking new brain tumour treatments.
-
£1.8M for novel synthetic factors to improve iPS technology
May 6Dr Abdenour Soufi, a Chancellor’s fellow and junior group leader at the MRC Centre for Regenerative Medicine (CRM), received a prestigious Medical Research Council (MRC) Career Development Award (CDA) earlier today.
-
Using cellular components to treat drug overdose
Apr 7It may be possible to treat paracetamol overdose in the future using microRNAs to silence transcription of genes that lead to the production of toxic metabolites. This is according to a proof-of-concept study carried out using stem cell models by researchers at the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh.
-
Blood stem cells study could pave the way for new cancer therapy
Mar 10People with leukaemia could be helped by new research that sheds light on how the body produces its blood supply.